Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
-$0.17 today
- Market cap
- $271.79M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
Volume 0.05M
Average 0.04M
TTRX Total Debt
Short-term and long-term borrowings combined.
Turn Therapeutics Inc.NASDAQ: TTRX
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt of $6.01M in Q1 FY2026
Q1 FY2026 total debt was $6.01M.
Context
- Total debt amounted to 32.2% of total assets at the end of Q1 FY2026.
- Total debt increased in 1 of the last 2 fiscal years.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 80.38K USD
- Year-over-year change
- -33.6%
- 2-year CAGR
- +78.7%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 80.38K | -33.6% |
| FY2024 | 2024-12-31 | 121.04K | +381.1% |
| FY2023 | 2023-12-31 | 25.16K | — |
Total Debt vs competitors
How TTRX compares with its peers on the latest reported figures
- TTRX's Mar 2026 total debt of $6.01M is the 4th highest of the 9 companies compared; the peer median is $460.96K.
- Total debt amounts to 32.2% of total assets for TTRX, versus a peer median of 1.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $304.46M | +230.8% | +62.2% | 163.3% | |
IRDOpus Genetics, Inc. | Mar 2026 | $25.93M | — | — | 38.8% |
| Mar 2026 | $23.03M | -9.4% | -7.5% | 8.5% | |
TTRXTurn Therapeutics Inc. | Mar 2026 | $6.01M | — | — | 32.2% |
| Mar 2026 | $465K | -26.8% | -24.4% | 1.3% | |
| Mar 2026 | $456.93K | +177.6% | +71.7% | 1.5% | |
| Apr 2026 | $184K | -16.7% | -2.6% | 1.2% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding TTRX) | $460.96K | -13.0% | -2.6% | 1.4% | |
Competitors are the stored peer set for TTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Turn Therapeutics Inc.
NASDAQ:TTRX
Intrinsic Alpha fair value
Locked
Current Price
$8.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.